74 related articles for article (PubMed ID: 1559223)
1. Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier.
Takada Y; Vistica DT; Greig NH; Purdon D; Rapoport SI; Smith QR
Cancer Res; 1992 Apr; 52(8):2191-6. PubMed ID: 1559223
[TBL] [Abstract][Full Text] [Related]
2. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system.
Greig NH; Momma S; Sweeney DJ; Smith QR; Rapoport SI
Cancer Res; 1987 Mar; 47(6):1571-6. PubMed ID: 3815357
[TBL] [Abstract][Full Text] [Related]
3. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
Cornford EM; Young D; Paxton JW; Finlay GJ; Wilson WR; Pardridge WM
Cancer Res; 1992 Jan; 52(1):138-43. PubMed ID: 1727374
[TBL] [Abstract][Full Text] [Related]
4. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.
Takada Y; Greig NH; Vistica DT; Rapoport SI; Smith QR
Cancer Chemother Pharmacol; 1991; 29(2):89-94. PubMed ID: 1760863
[TBL] [Abstract][Full Text] [Related]
5. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Begley DJ; Abbott NJ
J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
[TBL] [Abstract][Full Text] [Related]
6. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
Groothuis DR; Lippitz BE; Fekete I; Schlageter KE; Molnar P; Colvin OM; Roe CR; Bigner DD; Friedman HS
Cancer Res; 1992 Oct; 52(20):5590-6. PubMed ID: 1394182
[TBL] [Abstract][Full Text] [Related]
7. Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier.
O'Kane RL; Hawkins RA
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1167-73. PubMed ID: 12933350
[TBL] [Abstract][Full Text] [Related]
8. Regional cerebrovascular transport of leucine as measured by the in situ brain perfusion technique.
Smith QR; Takasato Y; Sweeney DJ; Rapoport SI
J Cereb Blood Flow Metab; 1985 Jun; 5(2):300-11. PubMed ID: 3988829
[TBL] [Abstract][Full Text] [Related]
9. Nutrient transport and the blood-brain barrier in developing animals.
Cornford EM; Cornford ME
Fed Proc; 1986 Jun; 45(7):2065-72. PubMed ID: 2872083
[TBL] [Abstract][Full Text] [Related]
10. Neutral amino acid transport at the human blood-brain barrier.
Pardridge WM; Choi TB
Fed Proc; 1986 Jun; 45(7):2073-8. PubMed ID: 3519291
[TBL] [Abstract][Full Text] [Related]
11. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
Duncan MW; Villacreses NE; Pearson PG; Wyatt L; Rapoport SI; Kopin IJ; Markey SP; Smith QR
J Pharmacol Exp Ther; 1991 Jul; 258(1):27-35. PubMed ID: 2072299
[TBL] [Abstract][Full Text] [Related]
12. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
[TBL] [Abstract][Full Text] [Related]
13. [Transport processes through the blood-brain barrier].
Lefauconnier JM
Reprod Nutr Dev; 1989; 29(6):689-702. PubMed ID: 2698167
[TBL] [Abstract][Full Text] [Related]
14. Transport of amantadine and rimantadine through the blood-brain barrier.
Spector R
J Pharmacol Exp Ther; 1988 Feb; 244(2):516-9. PubMed ID: 3346834
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system distribution kinetics of indinavir in rats.
Hamidi M
J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
[TBL] [Abstract][Full Text] [Related]
17. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier.
Poduslo JF; Curran GL; Haggard JJ; Biere AL; Selkoe DJ
Neurobiol Dis; 1997; 4(1):27-34. PubMed ID: 9258909
[TBL] [Abstract][Full Text] [Related]
18. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.
Tsuji A; Saheki A; Tamai I; Terasaki T
J Pharmacol Exp Ther; 1993 Dec; 267(3):1085-90. PubMed ID: 8263769
[TBL] [Abstract][Full Text] [Related]
19. The transport of leucine and aminocyclopentanecarboxylate across the intact, energy-depleted rat blood-brain barrier.
Greenwood J; Hazell AS; Pratt OE
J Cereb Blood Flow Metab; 1989 Apr; 9(2):226-33. PubMed ID: 2921297
[TBL] [Abstract][Full Text] [Related]
20. A bioreversible prodrug approach designed to shift mechanism of brain uptake for amino-acid-containing anticancer agents.
Killian DM; Chikhale PJ
J Neurochem; 2001 Feb; 76(4):966-74. PubMed ID: 11181816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
